• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Inter'l Jour. Inf. Dis. - Persistent attenuation of lymphocyte subsets after mass SARS-CoV-2 infection

sharon sanders

Editor-in-Chief & President
Research ArticleVolume 16310828

7February 2026

Open access
Download Full Issue


Persistent attenuation of lymphocyte subsets after mass SARS-CoV-2 infection

Zhengqi Jiang[SUP]1,#[/SUP] ∙ Tichao Shan[SUP]2,#[/SUP] ∙ Yucan Li[SUP]1[/SUP] ∙ … ∙ Heyu Ni[SUP]6,7[/SUP] ∙ Jun Peng[SUP]1[/SUP] ∙ Miao Xu[SUP]1[/SUP] miao.xu@sdu.edu.cn … Show more
Affiliations & NotesArticle Info


Highlights


SARS-CoV-2 causes lasting immune dysregulation for over 20 months.

The impact of SARS-CoV-2 on lymphocytes was especially severe in patients with CVD.

Lymphocyte deficiency is related to long COVID pathogenesis.

Long-term immune dysregulation of long COVID demands tailored treatment.


Abstract

Objectives

Growing evidence suggests that lymphocyte subsets are declined in COVID-19 patients, but it is unclear if these alterations persist after widespread exposure to SARS-CoV-2 or how long they last.

Methods

We analyzed lymphocyte subset data from 40,537 patients across three phases: pre-COVID, mass infection, and post-COVID. The counts of lymphocyte subsets and CD4[SUP]+[/SUP]/CD8[SUP]+[/SUP] ratios were compared using Mann–Whitney U test or Kruskal-Wallis H test. Monthly post-exposure data were compared with pre-exposure data to assess the persistence of impact on lymphocyte subsets by SARS-CoV-2, and subgroup analyses were performed in patients with cardiovascular disease.

Results

During mass infection, T cells, CD4[SUP]+[/SUP]T cells, CD8[SUP]+[/SUP]T cells, NK cells, and B cells dropped significantly. Even 20 months post-infection, CD8[SUP]+[/SUP] T cells remained 9.9% below baseline. Baseline lymphocyte subsets differed significantly by sex and age. Immune recovery varied by age and sex, with older adults and males showing prolonged lymphopenia. In cardiovascular disease patients, T lymphocytes remained 72.9% below baseline for 20 months post-infection.


Conclusion

Our findings redefine SARS-CoV-2 infection as a condition of long-lasting immune compromise. The sustained subnormal lymphocytes—particularly in cardiovascular disease cohorts—highlight a key immunologic feature of long COVID and underscore the need for personalized care.​

https://www.ijidonline.com/article/S1201-9712(25)00509-0/fulltext
 
Back
Top Bottom